MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Progressive supranuclear palsy presenting with corticobasal syndrome: a case report

M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)

Meeting: 2017 International Congress

Abstract Number: 250

Keywords: Corticobasal degeneration (CBD), Progressive supranuclear palsy(PSP), Tauopathies

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: Clinical description and interpretation of complementary diagnostic exams of a patient with probable PSP with corticobasal syndrome phenotype (PSP-CBS).

Background: Underlying pathologies of CBS are heterogeneous, but 70% of cases have a tauopathy. CBS, however, is a rare presentation of PSP and PSP-CBS comprises of only 4% of PSP cases.

Methods: A 78 years-old, female patient with a previous history of anxiety disorder developed at age of 77 years-old gait difficulties, loss of balance with frequent falls (mainly backwards) and cognitive complains. In the neuropsychological assessment, she scored 25 in MMSE and 14 in MoCA (12 years of education), affecting mainly executive functions. At neurological examination, she presented asymmetric blepharospasm, slow vertical saccades with vertical superior limitation, bilateral asymmetric limb apraxia much more marked in left side, dystonic posturing of left upper limb with motor overflow, progressive clumsiness of left upper limb with functional disability, bradykinesia, axial rigidity without appendicular rigidity and severe loss of postural reflexes. Treatment with levodopa/carbidopa was started until doses of 750 mg/day, with no clinical benefit. 

Results: The brain MRI presented a prominent midbrain atrophy with preserved pons dimensions (Hummingbird sign) and right side upper parietal lobe atrophy [Figure 1]. The beta-CIT PET revealed asymmetric bilateral dopaminergic deficit more evident in right side [Figure 2]. CSF biomarkers showed slight elevated levels of Tau and phosphorylated Tau protein with normal beta-amyloid levels. 

Conclusions: This case depicts the importance of confronting clinical and complementary diagnostic exams to reach the more accurate diagnosis possible, in vivo, and identify the different PSP variants. A better understanding of the factors that influence the selective pathological vulnerability in different PSP variants will provide further insights into neurodegenerative process underlying tauopathies. 

To cite this abstract in AMA style:

M. Sousa, R. Varela, C. Januário, A. Morgadinho. Progressive supranuclear palsy presenting with corticobasal syndrome: a case report [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/progressive-supranuclear-palsy-presenting-with-corticobasal-syndrome-a-case-report/. Accessed July 10, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/progressive-supranuclear-palsy-presenting-with-corticobasal-syndrome-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley